Latest / The Podcast by KevinMD

Oral Wegovy sounds easy, but the reality is more complicated
Is the new oral Wegovy pill a breakthrough or a risk most patients never hear about? Shiv K. Goel, an internal medicine and functional medicine physician, joins the show to unpack his KevinMD article, "Oral Wegovy: the miracle and the mess of the new GLP-1 pill," and why treating this drug casually could hurt you. He breaks down emerging data linking high-dose semaglutide to ischemic optic neuropathy, with reporting odds nearly five times higher for Wegovy than Ozempic, and explains why the obesity population faces unique hemodynamic risks. You will learn why he never prescribes a GLP-1…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.